Skip to main content

and
  1. Article

    Open Access

    Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis

    Despite the precise pathogenesis of atopic dermatitis (AD) is unknown, an immune dysregulation that causes Th2-predominant inflammation and an intrinsic defect in skin barrier function are currently the two ma...

    Francesca Abramo, Luca Campora, Francesco Albanese in BMC Veterinary Research (2014)

  2. Article

    Rimonabant Precipitates Anxiety in Rats Withdrawn from Palatable Food: Role of the Central Amygdala

    The anti-obesity medication rimonabant, an antagonist of cannabinoid type-1 (CB1) receptor, was withdrawn from the market because of adverse psychiatric side effects, including a negative affective state. We inve...

    Angelo Blasio, Attilio Iemolo, Valentina Sabino in Neuropsychopharmacology (2013)

  3. No Access

    Article

    Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB1 receptors: a keratinocyte-dependent effect

    Ultraviolet radiation is the major environmental insult to the skin and stimulates the synthesis of melanin in melanocytes, which then distribute it to the neighboring keratinocytes where it confers photo-prot...

    Sofia Magina, Carina Esteves-Pinto, Eduardo Moura in Archives of Dermatological Research (2011)

  4. Article

    Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels

    The endocannabinoid-inactivating enzyme, fatty acid amide hydrolase (FAAH), and the transient receptor potential vanilloid type-1 (TRPV1) channel are new targets for the development of anxiolytic drugs. We stu...

    Vincenzo Micale, Luigia Cristino, Alessandra Tamburella in Neuropsychopharmacology (2009)